Navidea Biopharmaceuticals, Inc. (NAVB) Social Stream

Featured Post From StockTwits About NAVB

$NAVB New SEC Filing: 8-K Earnings - NAVIDEA BIOPHARMACEUTICALS, INC. (0000810509) August 11


Item 2.02 Results of Operations and Financial Condition. On August 11, 2021, Navidea Biopharmaceuticals, Inc. (the "Company") issued a press release regarding its consolidated financial results for the quarter and year-to-date ended June 30, 2021. A copy of the Company's August 11, 2021 press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information contained in Item 2.02 of this Current Report on Form 8-K, including exhibit 99.1 attached hereto, shall not be treated as "filed" for purposes of the Securities Exchange Act of 1934, as amended. Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Exhibit (...)

https://mkn.re/95078